Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rachlis

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Acquired Immune Deficiency Syndromes|September 1, 1994
Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: results of the Canadian Open ddI Treatment ProgramJ S Montaner, A Rachlis, R Beaulieu, et al.
Tissue Antigens|October 22, 2009
Successful implementation of a national HLA-B*5701 genetic testing service in CanadaR G Lalonde, R Thomas, A Rachlis, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Foscarnet therapy of cytomegalovirus retinitis in AIDSM M Fanning, S E Read, M Benson, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|March 28, 2012
A prospective comparison of Porta-sonic and Fisoneb ultrasonic nebulizers for administering aerosol pentamidineA McIvor, D Flood, L Lee-Pack, et al.
AIDS (London, England)|February 10, 1998
Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study GroupD R Kuritzkes, D Parenti, D J Ward, et al.
Archives of Internal Medicine|June 1, 1985
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patientsR Feld, T J Louie, L Mandell, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1988
Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infectionsM G Bergeron, J Mendelson, G K Harding, et al.
International Journal of Dermatology|November 30, 2000
Epidemiology and prevalence of onychomycosis in HIV-positive individualsA K Gupta, P Taborda, V Taborda, et al.
AIDS Patient Care and Stds|July 27, 2007
Risk factors for grade 3-4 liver enzyme elevation in HIV and hepatitis C coinfected patients on combination antiretroviral therapyS Chihrin, T Antoniou, J Raboud, et al.
Annals of Internal Medicine|October 15, 1995
Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study GroupJ S Montaner, M T Schechter, A Rachlis, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Acquired Immune Deficiency Syndromes|September 1, 1994
Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: results of the Canadian Open ddI Treatment ProgramJ S Montaner, A Rachlis, R Beaulieu, et al.
Tissue Antigens|October 22, 2009
Successful implementation of a national HLA-B*5701 genetic testing service in CanadaR G Lalonde, R Thomas, A Rachlis, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Foscarnet therapy of cytomegalovirus retinitis in AIDSM M Fanning, S E Read, M Benson, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|March 28, 2012
A prospective comparison of Porta-sonic and Fisoneb ultrasonic nebulizers for administering aerosol pentamidineA McIvor, D Flood, L Lee-Pack, et al.
AIDS (London, England)|February 10, 1998
Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study GroupD R Kuritzkes, D Parenti, D J Ward, et al.
Archives of Internal Medicine|June 1, 1985
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patientsR Feld, T J Louie, L Mandell, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1988
Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infectionsM G Bergeron, J Mendelson, G K Harding, et al.
International Journal of Dermatology|November 30, 2000
Epidemiology and prevalence of onychomycosis in HIV-positive individualsA K Gupta, P Taborda, V Taborda, et al.
AIDS Patient Care and Stds|July 27, 2007
Risk factors for grade 3-4 liver enzyme elevation in HIV and hepatitis C coinfected patients on combination antiretroviral therapyS Chihrin, T Antoniou, J Raboud, et al.
Annals of Internal Medicine|October 15, 1995
Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study GroupJ S Montaner, M T Schechter, A Rachlis, et al.
Pageof 6